Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Fokam J, Chenwi CA, Tala V, Takou D, Santoro MM, Teto G, Dambaya B, Anubodem F, Semengue ENJ, Beloumou G, Djupsa S, Assomo E, Fokunang C, Alteri C, Billong S, Bouba NP, Ajeh R, Colizzi V, Mbanya D, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: chenwi ca. Viruses. 2023 Jun 28;15(7):1458. doi: 10.3390/v15071458. Viruses. 2023. PMID: 37515146 Free PMC article.
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings.
Fokam J, Ngoufack Jagni Semengue E, Molimbou E, Etame NK, Santoro MM, Takou D, Mossiang L, Meledie AP, Chenwi CA, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Ndjeyep SCD, Fainguem N, Abba A, Kengni AMN, Tchouaket MCT, Bouba NP, Billong SC, Djubgang R, Saounde ET, Sosso SM, Kouanfack C, Bissek AZ, Eben-Moussi E, Colizzi V, Perno CF, Ceccherini-Silberstein F, Ndjolo A. Fokam J, et al. Among authors: chenwi ca. Microbiol Spectr. 2022 Dec 21;10(6):e0342022. doi: 10.1128/spectrum.03420-22. Epub 2022 Oct 19. Microbiol Spectr. 2022. PMID: 36259973 Free PMC article.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Semengue ENJ, Fokam J, Etame NK, Molimbou E, Chenwi CA, Takou D, Mossiang L, Meledie AP, Yagai B, Nka AD, Dambaya B, Teto G, Ka'e AC, Beloumou GA, Djupsa Ndjeyep SC, Abba A, Kengni AMN, Tommo Tchouaket MC, Bouba NP, Billong SC, Sosso SM, Colizzi V, Perno CF, Kouanfack C, Zoung-Kanyi Bissek AC, Eben-Moussi E, Santoro MM, Ceccherini-Silberstein F, Ndjolo A. Semengue ENJ, et al. Among authors: chenwi ca. Viruses. 2022 Dec 21;15(1):18. doi: 10.3390/v15010018. Viruses. 2022. PMID: 36680058 Free PMC article.
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.
Fokam J, Ngoufack Jagni Semengue E, Armenia D, Takou D, Dambaya B, Teto G, Chenwi CA, Nka AD, Beloumou GA, Ndjeyep SCD, Tchouaket MCT, Fainguem N, Sosso SM, Colizzi V, Perno CF, Ndjolo A, Ceccherini-Silberstein F, Santoro MM. Fokam J, et al. Among authors: chenwi ca. Diagn Microbiol Infect Dis. 2022 Feb;102(2):115574. doi: 10.1016/j.diagmicrobio.2021.115574. Epub 2021 Oct 22. Diagn Microbiol Infect Dis. 2022. PMID: 34864527
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Mbouyap PR, Fokam J, Ngoufack Jagni Semengue E, Mossiang L, Takou D, Ambe Chenwi C, Nka AD, Dambaya B, Teto G, Angong Beloumou G, Djupsa Ndjeyep SC, Ka'e AC, Kouanfack C, Ndjolo A, Mbopi Keou FX. Mbouyap PR, et al. Among authors: ambe chenwi c. Medicine (Baltimore). 2023 Jun 2;102(22):e33897. doi: 10.1097/MD.0000000000033897. Medicine (Baltimore). 2023. PMID: 37266631 Free PMC article.
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000.
Fokam J, Takou D, Nka AD, Ka'e AC, Yagai B, Ambe Chenwi C, Ngoufack Jagni Semengue E, Angong Beloumou G, Djupsa Ndjeyep SC, Abba A, Pabo W, Gouissi D, Tommo Tchouaket MC, Yatchou L, Zam K, Mama L, Ekitti RC, Fainguem N, Kamgaing R, Sosso SM, Ndembi N, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Among authors: ambe chenwi c. J Public Health Afr. 2022 May 24;13(1):2142. doi: 10.4081/jphia.2022.2142. eCollection 2022 May 24. J Public Health Afr. 2022. PMID: 35720804 Free PMC article.
High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon.
Fainguem NN, Fokam J, Ngoufack Jagni Semengue E, Durand Nka A, Takou D, Ageboh Nkembi-Leke J, Alteri C, Colagrossi L, Yagai RB, Ambe Chenwi C, Tchouaket Tommo MC, Angong Beloumou G, Ka'e AC, Ndjeyep Djupsa SC, Abba A, Heunko Yatchou LG, Nnomo Zam K, Kamgaing R, Sosso SM, Mama L, Ndembi N, Colizzi V, Perno CF, Cappelli G, Ndjolo A. Fainguem NN, et al. Among authors: ambe chenwi c. J Public Health Afr. 2022 May 24;13(1):2163. doi: 10.4081/jphia.2022.2163. eCollection 2022 May 24. J Public Health Afr. 2022. PMID: 35720798 Free PMC article.
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Fokam J, Chenwi CA, Takou D, Santoro MM, Tala V, Teto G, Beloumou G, Semengue ENJ, Dambaya B, Djupsa S, Kembou E, Bouba NP, Ajeh R, Cappelli G, Mbanya D, Colizzi V, Ceccherini-Silberstein F, Perno CF, Ndjolo A. Fokam J, et al. Among authors: chenwi ca. Viruses. 2023 Aug 2;15(8):1683. doi: 10.3390/v15081683. Viruses. 2023. PMID: 37632026 Free PMC article.
15 results